This Biotech Stock Is Surging Over Potential COVID-19 Drug

March 18, 2020 CCN

Regeneron is speeding up the development of a therapy against COVID-19. Investors welcomed the news by bidding up company stock.

The post This Biotech Stock Is Surging Over Potential COVID-19 Drug appeared first on CCN.com

Source: https://www.ccn.com/biotech-giant-says-its-covid-19-drug-can-potentially-prevent-and-treat-infections/

Stay up to date

on all important crypto news!

The most important news, once a week. No spam.

Close this popup